SCHEMBL5240271

SCHEMBL5240271

NC(=O)c1ccc(OCCC2CCCN2)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.51
SSTR2 P30874 1/20 0.48
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
MKNK1 Q9BUB5 1/20 0.39
HPGD P15428 1/20 0.39
PIM1 P11309 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
DPP4 P27487 1/20 0.38
PREP P48147 1/20 0.38
FAP Q12884 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP9 Q86TI2 1/20 0.38
DPP7 Q9UHL4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4201146 0.85 MAPK1 (0.54) CHEK2SSTR2CHRNB4CHRNA3HPGD
SCHEMBL4263220 0.82 CHEK2 (0.54) CHEK2SSTR2CHRNB4CHRNA3HPGD
SCHEMBL5239690 0.82 SSTR2 (0.41) SSTR2HSP90AA1HSP90AB1CHRNB4CHRNA3
SCHEMBL5247466 0.81 HTR2A (0.47) CHEK2SSTR2
SCHEMBL5243021 0.78 SSTR2 (0.50) CHEK2SSTR2
SCHEMBL5243204 0.77 HTR2A (0.46) CHEK2
SCHEMBL6027576 0.77 MAP2K1 (0.46) CHEK2CHRNB4CHRNA3
SCHEMBL11459124 0.76 SLC6A2 (0.53) CHRNB4CHRNA3PIM1PIM2
SCHEMBL5243165 0.75 HTR2A (0.47) CHEK2SSTR2
SCHEMBL5152692 0.74 CHRNA3 (0.54) CHRNB4CHRNA3DPP4PREPFAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828207-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2007-09-05 EP disclosed
WO-2006066174-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2006-06-22 WO disclosed